DOCSLIB.ORG

FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub Ã

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub à Ranking Instituciones No Académicas por sub área OCDE 2020 3. Ciencias Médicas y de la Salud > 3.02 Medicina Clínica PAÍS INSTITUCIÓN RANKING PUNTAJE USA VA Boston Healthcare System 1 5,000 FRANCE Assistance Publique Hopitaux Paris (APHP) 2 5,000 USA UTMD Anderson Cancer Center 3 5,000 USA Mayo Clinic 4 5,000 USA Memorial Sloan Kettering Cancer Center 5 5,000 USA Dana-Farber Cancer Institute 6 5,000 USA Massachusetts General Hospital 7 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 8 5,000 USA National Institutes of Health (NIH) - USA 9 5,000 FRANCE UNICANCER 10 5,000 USA Harvard School of Dental Medicine 11 5,000 CANADA University Health Network Toronto 12 5,000 USA Cleveland Clinic Foundation 13 5,000 USA Johns Hopkins Medicine 14 5,000 FRANCE Gustave Roussy 15 5,000 NETHERLANDS Erasmus University Medical Center 16 5,000 GERMANY Helmholtz Association 17 5,000 NETHERLANDS Academic Medical Center Amsterdam 18 5,000 SPAIN CIBER - Centro de Investigacion Biomedica en Red 19 5,000 USA Beth Israel Deaconess Medical Center 20 5,000 SWITZERLAND Roche Holding 21 5,000 CANADA Princess Margaret Cancer Centre 22 5,000 USA H Lee Moffitt Cancer Center & Research Institute 23 5,000 SPAIN Hospital Universitari Vall d'Hebron 24 5,000 BELGIUM University Hospital Leuven 25 5,000 USA NIH National Cancer Institute (NCI) 26 5,000 SPAIN Hospital Clinic de Barcelona 27 5,000 USA Bristol-Myers Squibb 28 5,000 USA Merck & Company 29 5,000 UNITED KINGDOM Royal Marsden NHS Foundation Trust 30 5,000 SOUTH KOREA Seoul National University Hospital 31 5,000 USA Sarah Cannon Research Institute 32 5,000 UNITED KINGDOM The Royal Marsden Hospital - London 33 5,000 SWITZERLAND Novartis 34 5,000 USA Genentech 35 5,000 NETHERLANDS Utrecht University Medical Center 36 5,000 SOUTH KOREA Yonsei University Health System 37 5,000 SOUTH KOREA Samsung Medical Center 38 5,000 USA Fred Hutchinson Cancer Center 39 5,000 FRANCE CHU Lyon 40 5,000 UNITED KINGDOM AstraZeneca 41 5,000 GERMANY German Cancer Research Center (DKFZ) 42 5,000 FRANCE Centre National de la Recherche Scientifique (CNRS) 43 5,000 DENMARK Rigshospitalet 44 5,000 FRANCE CHU Lille 45 5,000 USA Cedars Sinai Medical Center 46 5,000 FRANCE Hopital Universitaire Pitie-Salpetriere - APHP 47 5,000 UNITED KINGDOM Guy's & St Thomas' NHS Foundation Trust 48 5,000 USA Fox Chase Cancer Center 49 5,000 USA Boston Children's Hospital 50 5,000 JAPAN National Cancer Center - Japan 51 4,999 AUSTRALIA Peter Maccallum Cancer Center 52 4,998 Página 1 Ranking Instituciones No Académicas por sub área OCDE 2020 3. Ciencias Médicas y de la Salud > 3.02 Medicina Clínica PAÍS INSTITUCIÓN RANKING PUNTAJE AUSTRALIA Florey Institute of Neuroscience & Mental Health 53 4,998 FRANCE Assistance Publique-Hopitaux de Marseille 54 4,997 USA City of Hope 55 4,996 USA Childrens Hospital of Philadelphia 56 4,995 USA US Department of Veteran Affairs 57 4,994 FRANCE CHU Bordeaux 58 4,994 FRANCE CHU de Toulouse 59 4,993 ITALY Fondazione IRCCS Istituto Nazionale Tumori Milan 60 4,992 NETHERLANDS Netherlands Cancer Institute 61 4,991 TAIWAN National Taiwan University Hospital 62 4,990 CANADA Sunnybrook Health Science Center 63 4,990 SPAIN IDIBAPS 64 4,989 CANADA Sunnybrook Research Institute 65 4,988 SWITZERLAND World Health Organization 66 4,987 FRANCE Hopital Universitaire Saint-Louis - APHP 67 4,986 USA Tennessee Oncology 68 4,986 USA NewYork-Presbyterian Hospital 69 4,985 UNITED KINGDOM Institute of Cancer Research - UK 70 4,984 USA AbbVie 71 4,983 CHINA Chinese Academy of Medical Sciences - Peking Union Medical College 72 4,982 USA Pfizer 73 4,982 USA Cincinnati Children's Hospital Medical Center 74 4,981 CANADA Ottawa Hospital Research Institute 75 4,980 ITALY IRCCS Ca Granda Ospedale Maggiore Policlinico 76 4,979 ISRAEL Chaim Sheba Medical Center 77 4,978 USA Gilead Sciences 78 4,978 FINLAND Helsinki University Central Hospital 79 4,977 FRANCE CHU de Montpellier 80 4,976 CANADA British Columbia Cancer Agency 81 4,975 USA Kaiser Permanente 82 4,974 CANADA Hospital for Sick Children (SickKids) 83 4,974 USA Barbara Ann Karmanos Cancer Institute 84 4,973 GERMANY EBERHARD KARLS UNIVERSITY HOSPITAL 85 4,972 UNITED KINGDOM King's College Hospital NHS Foundation Trust 86 4,971 USA American Cancer Society 87 4,970 USA Northwell Health 88 4,970 FRANCE Hopital Universitaire Saint-Antoine - APHP 89 4,969 SWITZERLAND University Hospital of Bern 90 4,968 USA Children's Hospital Colorado 91 4,967 SPAIN Hospital Universitario 12 de Octubre 92 4,966 FRANCE Hopital Universitaire Cochin - APHP 93 4,966 UNITED KINGDOM Christie NHS Foundation Trust 94 4,965 USA James Cancer Hospital & Solove Research Institute 95 4,964 FRANCE Hopital Universitaire Henri-Mondor - APHP 96 4,963 SWITZERLAND Centre Hospitalier Universitaire Vaudois (CHUV) 97 4,962 NETHERLANDS VU UNIVERSITY MEDICAL CENTER 98 4,962 UNITED KINGDOM University College London Hospitals NHS Foundation Trust 99 4,961 GERMANY Schleswig Holstein University Hospital 100 4,960 FRANCE Hopital Universitaire Beaujon - APHP 101 4,959 AUSTRALIA Royal Melbourne Hospital 102 4,959 USA University of Illinois Chicago Hospital 103 4,958 CANADA Saint Michaels Hospital Toronto 104 4,957 Página 2 Ranking Instituciones No Académicas por sub área OCDE 2020 3. Ciencias Médicas y de la Salud > 3.02 Medicina Clínica PAÍS INSTITUCIÓN RANKING PUNTAJE USA Rutgers State University Medical Center 105 4,956 USA UCSF Helen Diller Family Comprehensive Cancer Center 106 4,955 FRANCE CNRS - National Institute for Biology (INSB) 107 4,955 USA Roswell Park Cancer Institute 108 4,954 FRANCE Centre Leon Berard 109 4,953 BELGIUM Ghent University Hospital 110 4,952 SOUTH KOREA Asan Medical Center 111 4,951 FRANCE CHU de Nantes 112 4,951 SPAIN CIBEREHD 113 4,950 FRANCE CHU de Nancy 114 4,949 ITALY IRCCS Istituto Oncologico Veneto (IOV) 115 4,948 USA Centers for Disease Control & Prevention - USA 116 4,947 USA Johnson & Johnson 117 4,947 UNITED KINGDOM King's College Hospital 118 4,946 FRANCE CHU Grenoble Alpes 119 4,945 USA Ann & Robert H. Lurie Children's Hospital of Chicago 120 4,944 SWEDEN Skane University Hospital 121 4,943 USA Eli Lilly 122 4,943 FRANCE Hopital Universitaire Europeen Georges-Pompidou - APHP 123 4,942 USA NIH National Heart Lung & Blood Institute (NHLBI) 124 4,941 SPAIN Vall d'Hebron Institut d'Oncologia (VHIO) 125 4,940 JAPAN Aichi Cancer Center 126 4,939 USA Amgen 127 4,939 USA Montefiore Medical Center 128 4,938 DENMARK Odense University Hospital 129 4,937 FRANCE CHU Strasbourg 130 4,936 FRANCE CHU Rennes 131 4,935 ITALY IRCCS European Institute of Oncology (IEO) 132 4,935 GERMANY Goethe University Frankfurt Hospital 133 4,934 GERMANY CARL GUSTAV CARUS UNIVERSITY HOSPITAL 134 4,933 USA University of California Los Angeles Medical Center 135 4,932 USA Henry Ford Hospital 136 4,931 CHINA Chinese Academy of Sciences 137 4,931 FRANCE International Agency for Research on Cancer (IARC) 138 4,930 GERMANY Boehringer Ingelheim 139 4,929 FRANCE Institut Curie 140 4,928 ITALY A.O.U. Citta della Salute e della Scienza di Torino 141 4,927 CANADA Sinai Health System Toronto 142 4,927 SPAIN Catalan Institute of Oncology 143 4,926 USA Huntsman Cancer Institute 144 4,925 USA Seattle Children's Hospital 145 4,924 TAIWAN Taipei Veterans General Hospital 146 4,923 USA Robert H. Lurie Comprehensive Cancer Center 147 4,923 BELGIUM Institut Jules Bordet 148 4,922 TAIWAN Chang Gung Memorial Hospital 149 4,921 UNITED KINGDOM GlaxoSmithKline 150 4,920 USA University of Kansas Medical Center 151 4,919 UNITED KINGDOM Royal Free London NHS Foundation Trust 152 4,919 POLAND Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology 153 4,918 USA The Methodist Hospital System 154 4,917 USA The Methodist Hospital - Houston 155 4,916 USA Angeles Clinic & Research Institute 156 4,915 Página 3 Ranking Instituciones No Académicas por sub área OCDE 2020 3. Ciencias Médicas y de la Salud > 3.02 Medicina Clínica PAÍS INSTITUCIÓN RANKING PUNTAJE ITALY Consiglio Nazionale delle Ricerche (CNR) 157 4,915 AUSTRALIA Royal North Shore Hospital 158 4,914 UNITED KINGDOM Addenbrooke's Hospital 159 4,913 UNITED KINGDOM Barts Health NHS Trust 160 4,912 FRANCE Hopital Universitaire Necker-Enfants Malades - APHP 161 4,911 USA Tufts Medical Center 162 4,911 UNITED KINGDOM Cancer Research UK 163 4,910 FRANCE CHU Tours 164 4,909 USA St Jude Children's Research Hospital 165 4,908 SPAIN Hospital Universitario Ramon y Cajal 166 4,907 BELGIUM Cliniques Universitaires Saint-Luc 167 4,907 USA Swedish Medical Center 168 4,906 SOUTH KOREA National Cancer Center - Korea (NCC) 169 4,905 USA Case Western Reserve University Hospital 170 4,904 FRANCE CHU Nice 171 4,903 USA Stanford Cancer Institute 172 4,903 UNITED KINGDOM Saint James's University Hospital 173 4,902 AUSTRALIA Austin Research Institute 174 4,901 USA University of Nebraska Medical Center 175 4,900 FRANCE Hopital Universitaire Bichat-Claude Bernard - APHP 176 4,899 ITALY IRCCS Fondazione Pascale 177 4,899 SPAIN Consejo Superior de Investigaciones Cientificas (CSIC) 178 4,898 FRANCE Hopital Universitaire Bicetre - APHP 179 4,897 NEW ZEALAND Auckland City Hospital 180 4,896 SPAIN Catalan Health Institute 181 4,895 USA Johnson & Johnson USA 182 4,895 SPAIN Virgen del Rocio University Hospital 183 4,894 USA Broad Institute 184 4,893 SPAIN Hospital Germans Trias i Pujol 185 4,892 UNITED KINGDOM Royal Brompton Hospital 186 4,891 USA University of Chicago Medical Center 187 4,891 FRANCE Hopital Universitaire Ambroise-Pare - APHP 188 4,890 ITALY Azienda Ospedaliero Universitaria Careggi
Load more

Recommended publications
  • Alfred Nobel
    www.bibalex.org/bioalex2004conf The BioVisionAlexandria 2004 Conference Newsletter November 2003 Volume 1, Issue 2 BioVisionAlexandria ALFRED NOBEL 2004 aims to celebrate the The inventor, the industrialist outstanding scientists and scholars, in a he Nobel Prize is one of the highest distinctions recognized, granting its winner century dominated by instant fame. However, many do not know the interesting history and background technological and T that led to this award. scientific revolutions, through its It all began with a chemist, known as Alfred Nobel, born in Stockholm, Sweden in 1833. Nobel Day on 3 April Alfred Nobel moved to Russia when he was eight, where his father, Immanuel Nobel, 2004! started a successful mechanical workshop. He provided equipment for the Russian Army and designed naval mines, which effectively prevented the British Royal Navy from moving within firing range of St. Petersburg during the Crimean War. Immanuel Nobel was also a pioneer in the manufacture of arms, and in designing steam engines. INSIDE Scientific awards .........3 Immanuel’s success enabled him to Alfred met Ascanio Sobrero, the Italian Confirmed laureates ....4 Lady laureates ............7 provide his four sons with an excellent chemist who had invented Nitroglycerine education in natural sciences, languages three years earlier. Nitroglycerine, a and literature. Alfred, at an early age, highly explosive liquid, was produced by acquired extensive literary knowledge, mixing glycerine with sulfuric and nitric mastering many foreign languages. His acid. It was an invention that triggered a Nobel Day is interest in science, especially chemistry, fascination in the young scientist for many dedicated to many of was also apparent.
    [Show full text]
  • NIH Public Access Author Manuscript Nat Genet
    NIH Public Access Author Manuscript Nat Genet. Author manuscript; available in PMC 2013 October 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Nat Genet. 2013 April ; 45(4): 371–384e2. doi:10.1038/ng.2566. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Stig E Bojesen1,2,*, Karen A Pooley3,*, Sharon E Johnatty4,*, Jonathan Beesley4,*, Kyriaki Michailidou3,*, Jonathan P Tyrer5,*, Stacey L Edwards6, Hilda A Pickett7,8, Howard C Shen9, Chanel E Smart10, Kristine M Hillman6, Phuong L Mai11, Kate Lawrenson9, Michael D Stutz7,8, Yi Lu4, Rod Karevan9, Nicholas Woods12, Rebecca L Johnston10, Juliet D French6, Xiaoqing Chen4, Maren Weischer1,2, Sune F Nielsen1,2, Melanie J Maranian5, Maya Ghoussaini5, Shahana Ahmed5, Caroline Baynes5, Manjeet K Bolla3, Qin Wang3, Joe Dennis3, Lesley McGuffog3, Daniel Barrowdale3, Andrew Lee3, Sue Healey4, Michael Lush3, Daniel C Tessier13,14, Daniel Vincent13,14, Françis Bacot13,14, Study Group members15, Ignace Vergote16,17, Sandrina Lambrechts16,17, Evelyn Despierre16,17, Harvey A Risch18, Anna González-Neira19, Mary Anne Rossing20,21, Guillermo Pita19, Jennifer A Doherty22, Nuria Álvarez19, Melissa C Larson23, Brooke L Fridley23, Nils Schoof24, Jenny Chang- Claude25, Mine S Cicek26, Julian Peto27, Kimberly R Kalli28, Annegien Broeks29, Sebastian M Armasu23, Marjanka K Schmidt29,30, Linde M Braaf29, Boris Winterhoff31, Heli Nevanlinna32, Gottfried E Konecny33, Diether Lambrechts34,35,
    [Show full text]
  • Balcomk41251.Pdf (558.9Kb)
    Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr.
    [Show full text]
  • Timeline of Immunology
    TIMELINE OF IMMUNOLOGY 1549 – The earliest account of inoculation of smallpox (variolation) occurs in Wan Quan's (1499–1582) 1718 – Smallpox inoculation in Ottoman Empire realized by West. Lady Mary Wortley Montagu, the wife of the British ambassador to Constantinople, observed the positive effects of variolation on the native population and had the technique performed on her own children. 1796 – First demonstration of smallpox vaccination (Edward Jenner) 1837 – Description of the role of microbes in putrefaction and fermentation (Theodore Schwann) 1838 – Confirmation of the role of yeast in fermentation of sugar to alcohol (Charles Cagniard-Latour) 1840 – Proposal of the germ theory of disease (Jakob Henle) 1850 – Demonstration of the contagious nature of puerperal fever (childbed fever) (Ignaz Semmelweis) 1857–1870 – Confirmation of the role of microbes in fermentation (Louis Pasteur) 1862 – Phagocytosis (Ernst Haeckel) 1867 – Aseptic practice in surgery using carbolic acid (Joseph Lister) 1876 – Demonstration that microbes can cause disease-anthrax (Robert Koch) 1877 – Mast cells (Paul Ehrlich) 1878 – Confirmation and popularization of the germ theory of disease (Louis Pasteur) 1880 – 1881 -Theory that bacterial virulence could be attenuated by culture in vitro and used as vaccines. Proposed that live attenuated microbes produced immunity by depleting host of vital trace nutrients. Used to make chicken cholera and anthrax "vaccines" (Louis Pasteur) 1883 – 1905 – Cellular theory of immunity via phagocytosis by macrophages and microphages (polymorhonuclear leukocytes) (Elie Metchnikoff) 1885 – Introduction of concept of a "therapeutic vaccination". Report of a live "attenuated" vaccine for rabies (Louis Pasteur and Pierre Paul Émile Roux). 1888 – Identification of bacterial toxins (diphtheria bacillus) (Pierre Roux and Alexandre Yersin) 1888 – Bactericidal action of blood (George Nuttall) 1890 – Demonstration of antibody activity against diphtheria and tetanus toxins.
    [Show full text]
  • Journal of Immunodeficiency & Disorders
    Kobayashi, J Immunodefic Disor 2012, 1:1 http://dx.doi.org/10.4172/2324-853X.1000e102 Journal of Immunodeficiency & Disorders Editorial a SciTechnol journal MHC class II genes [5]. Interestingly, CIITA can activate not only NLRC5/CITA: A Novel the promoters of MHC class II genes but also of MHC class I genes at least in in vitro experiments [6-10]. However, mutations in the CIITA Regulator of Class I Major gene in human BLS patients and deficiency of CIITA in mice did not show any reduction of MHC class I [2,11-14]. This led to the obvious Histocompatibility Complex assumption that a similar unknown transactivator should exist for the Genes regulation of expression of MHC class I genes. Koichi S. Kobayashi1* Seventeen years after the discovery of CIITA, the MHC class I transactivator was identified. Similar to CIITA, it is a member of In 1936, Peter Gorer reported one of the most significant work NLR (nucleotide binding domain-leucine rich repeats containing) in the history of immunology; the first identification of alloantigen family of proteins, called NLRC5 [15,16]. NLRC5 has unusually long using serum from immunized rabbits and his own blood [1]. This led leucine-rich repeats and its N-terminal structure was different from to the discovery of the Major Histocompatibility Complex (MHC) that of CIITA [16,17]. Because of this, these two proteins look very different at first sight. However, upon detailed phylogenetic analysis by his coworker, George Snell at the Jackson Laboratories. After of the nucleotide binding domain, it became clear that NLRC5 is the three quarters of a century, this year, 5 laboratories independently most closely related to CIITA among all NLR proteins [15,18].
    [Show full text]
  • Nobel Laureates in Physiology Or Medicine
    All Nobel Laureates in Physiology or Medicine 1901 Emil A. von Behring Germany ”for his work on serum therapy, especially its application against diphtheria, by which he has opened a new road in the domain of medical science and thereby placed in the hands of the physician a victorious weapon against illness and deaths” 1902 Sir Ronald Ross Great Britain ”for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it” 1903 Niels R. Finsen Denmark ”in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science” 1904 Ivan P. Pavlov Russia ”in recognition of his work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged” 1905 Robert Koch Germany ”for his investigations and discoveries in relation to tuberculosis” 1906 Camillo Golgi Italy "in recognition of their work on the structure of the nervous system" Santiago Ramon y Cajal Spain 1907 Charles L. A. Laveran France "in recognition of his work on the role played by protozoa in causing diseases" 1908 Paul Ehrlich Germany "in recognition of their work on immunity" Elie Metchniko France 1909 Emil Theodor Kocher Switzerland "for his work on the physiology, pathology and surgery of the thyroid gland" 1910 Albrecht Kossel Germany "in recognition of the contributions to our knowledge of cell chemistry made through his work on proteins, including the nucleic substances" 1911 Allvar Gullstrand Sweden "for his work on the dioptrics of the eye" 1912 Alexis Carrel France "in recognition of his work on vascular suture and the transplantation of blood vessels and organs" 1913 Charles R.
    [Show full text]
  • History of Clinical Transplantation
    World J. Surg. 2.:&.759-782.2000 DOl: 10.1007/s00268001012':& History of Clinical Transplantation Thomas E. Starzl, M.D., Ph.D. Thomas E. Starzl Transplantation Institute. University of Pittsburgh Medical Center. Falk Clinic. 4th Floor, 3601 Fifth Avenue. Pittsburgh. Pennsylvania 15213. USA Abstract. The emergence of transplantation has seen the development of to donor strain tissues was retained as the recipient animals grew increasingly potent immunosuppressive agents, progressively better to adult life, whereas normal reactivity evolved to third party methods of tissue and organ preservation. refinements in histocompati­ grafts and other kinds of antigens. bility matching. and numerous innovations in surgical techniques. Such efforts in combination ultimately made it possible to successfully engraft This was not the first demonstration that tolerance could be all of the organs and bone marrow cells in humans. At a more fundamen· deliberately produced. Analogous to the neonatal transplant tal level, however, the transplantation enterprise hinged on two seminal model. Traub [6] showed in 1936 that the lymphocytic choriomen­ turning points. The first was the recognition by Billingham. Brent, and Medawar in 1953 that it was possible to induce chimerism·associated igitis virus (LCMV) persisted after transplacental infection of the neonatal tolerance deliberately. This discovery escalated over the next 15 embryo from the mother or. alternatively. by injection into new­ years to the first successful bone marrow transplantations in humans in born mice. Howevt!r, when the mice were infected as adults. the 1968. The second turning point was the demonstration during the early virus was eliminated immunologicully. Similar observations had 1960s that canine and human organ allografts could self·induce tolerance been made in experimental tumor models.
    [Show full text]
  • Ssfaoggi 201306
    SOCIETA’ DI SCIENZE FARMACOLOGICHE APPLICATE SOCIETY FOR APPLIED PHARMACOLOGICAL SSFAoggi SCIENCES Notiziario di Medicina Farmaceutica Giugno 2013 Bimestrale della Società di Scienze Farmacologiche Applicate Fondata nel 1964 numero 37 Dove sono i nuovi antibiotici? Sommario: La comunità mondiale sta correndo un grosso rischio: questo ci ricordano due editoriali, Editoriale 1 pubblicati su The Lancet e sul British Medical Journal, che riportiamo alle pagine 21 e 22. La resistenza agli antibiotici è un grave problema: The Lancet ci ricorda che fu addirittura Novità in Farmacovigilanza messa in evidenza dallo stesso Alexander Fleming nel 1945, il quale temeva che l’abuso Parte prima 2 della penicillina potesse selezionare ceppi resistenti. Il British Medical Journal evidenzia che molte pratiche mediche e chirurgiche (dall’uso Novità in Farmacovigilanza della chemioterapia agli interventi invasivi in ortopedia e cardiochirurgia) sono possibili Parte seconda 4 grazie alla profilassi con antibiotici. E quindi, la resistenza agli antibiotici non è un solo un problema degli infettivologi, ma sta diventando un problema dei chirurghi, degli oncologi, e Il Decreto Balduzzi 6 di tutto il sistema sanitario. Alcune previsioni sono drammatiche: l’intervento di protesi dell’anca, che è diventato una Farmaci a brevetto scaduto 12 routine per la popolazione anziana, potrebbe essere colpito in modo significativo da com- plicanze infettive, passando dall’1% dei pazienti di oggi fino al 40%-50% dei pazienti nel Affari Istituzionali 12 prossimo futuro, con oltre un terzo di essi in pericolo di vita. Uno scenario davvero preoc- 5a Edizione Master Bicocca 13 cupante. Di fronte a queste previsioni, che ci vengono ormai ripetute ad intervalli regolari, stupisce Master Bicocca 2013: i numeri 13 la mancanza di incentivi per la ricerca di nuovi antibiotici.
    [Show full text]
  • Brief History of Important Immunologic Discoveries and Developments
    Brief History of Important Immunologic Discoveries and Developments Year Event Author(s) 1798 Cowpox vaccination Edward Jenner 1866 Wound disinfection Joseph Lister 1876 Discovery of B. antracis, foundation of Robert Koch bacteriology 1880 Discovery of attenuated vaccine by Louis Pasteur invitro passages 1883 Phagocytosis, cellular immunity theory Elie I. I. Metchnikoff 1888 Discovery of bacterial toxins P. P. Emile Roux and Alexandre E. J. Y ersin 1890 Discovery of antitoxins, foundation of Emil A. von Behring and serotherapy Shibasaburo Kitasato 1894 Immunologic bacteriolysis Richard F. J. Pfeiffer and Vasily I. Isaeff 1894 Discovery of antibody and complement Jules J.B. V. Bordet activity as the active factors in bacteriolysis 1896 Discovery of specific agglutination Herbert E. Durham and Max von Gruber 1896 Agglutination test for the diagnosis of Georges F. I. Widal and typhoid (Widal test) Jean-Marie-Athanase Sicard 1900 Formulation of side-chain theory of anti- Paul Ehrlich body formation 1900 Discovery of A, B, 0 blood groups Karl Landsteiner 1900 Development of complement fixation Jules J.B. V. Bordet and reaction Octave Gengou 1902 Discovery of anaphylaxis Charles R. Richet and Paul Portier 1903 Local anaphylaxis due to antibody- Nicholas M. Arthus antigen complex: Arthus reaction 1903 Discovery of opsonization Almroth E. Wright and Steward R. Douglas 440 Brief History of Important Immunologic Discoveries and Developments Year Event Author(s) 1905 Description of serum sickness Clemens von Pirquet and Bela Schick 1910 Introduction of salvarsan, later neo- Paul Ehrlich and Sahachiro Hata salvarsan, foundation of chemotherapy of infections 1910 Development of anaphylaxis test William Schultz (Schultz-Dale) 1914 Formulation of genetic theory of tumor Clarence C.
    [Show full text]
  • List of Nobel Laureates 1
    List of Nobel laureates 1 List of Nobel laureates The Nobel Prizes (Swedish: Nobelpriset, Norwegian: Nobelprisen) are awarded annually by the Royal Swedish Academy of Sciences, the Swedish Academy, the Karolinska Institute, and the Norwegian Nobel Committee to individuals and organizations who make outstanding contributions in the fields of chemistry, physics, literature, peace, and physiology or medicine.[1] They were established by the 1895 will of Alfred Nobel, which dictates that the awards should be administered by the Nobel Foundation. Another prize, the Nobel Memorial Prize in Economic Sciences, was established in 1968 by the Sveriges Riksbank, the central bank of Sweden, for contributors to the field of economics.[2] Each prize is awarded by a separate committee; the Royal Swedish Academy of Sciences awards the Prizes in Physics, Chemistry, and Economics, the Karolinska Institute awards the Prize in Physiology or Medicine, and the Norwegian Nobel Committee awards the Prize in Peace.[3] Each recipient receives a medal, a diploma and a monetary award that has varied throughout the years.[2] In 1901, the recipients of the first Nobel Prizes were given 150,782 SEK, which is equal to 7,731,004 SEK in December 2007. In 2008, the winners were awarded a prize amount of 10,000,000 SEK.[4] The awards are presented in Stockholm in an annual ceremony on December 10, the anniversary of Nobel's death.[5] As of 2011, 826 individuals and 20 organizations have been awarded a Nobel Prize, including 69 winners of the Nobel Memorial Prize in Economic Sciences.[6] Four Nobel laureates were not permitted by their governments to accept the Nobel Prize.
    [Show full text]
  • Printwhatyoulike on ノーベル生理学・医学賞
    ノーベル生理学・医学賞 出典: フリー百科事典『ウィキペディア（Wikipedia）』 ノーベル賞 > ノーベル生理学・医学賞 ノーベル生理学・医学賞（ノーベルせいりがく・いがくしょう）はノーベル賞6部門のうちの1つ。「（動物）生理学及び医学の分野で 最も重要な発見を行なった」人に与えられる。選考はカロリンスカ研究所のノーベル賞委員会が行う。 歴代受賞者 [編集] 年度 受賞者名 国籍 受賞理由 エミール・アドルフ・フォン・ 血清療法の研究、特にジフテリアに対するものによって、 1901 ベーリング ドイツ帝国 医学の新しい分野を切り開き、生理学者の手に疾病や死 年 Emil Adolf von Behring に勝利しうる手段を提供したこと 1902 ロナルド・ロス マラリアの研究によってその感染経路を示し、疾病やそれ イギリス 年 Ronald Ross に対抗する手段に関する研究の基礎を築いたこと 1903 ニールス・フィンセン 疾病の治療法への寄与、特に尋常性狼瘡への光線治療法 デンマーク 年 Niels Ryberg Finsen によって、医学の新しい領域を開拓したこと 1904 イワン・パブロフ 消化生理の研究により、その性質に関する知見を転換し ロシア連邦 年 Ivan Petrovich Pavlov 拡張したこと 1905 ロベルト・コッホ ドイツ帝国 結核に関する研究と発見 年 Robert Koch カミッロ・ゴルジ イタリア王国 Camillo Golgi 1906 神経系の構造研究 年 サンティアゴ・ラモン・イ・カ ハール スペイン Santiago Ramon y Cajal シャルル・ルイ・アルフォンス・ 1907 ラヴラン フランス 疾病発生における原虫類の役割に関する研究 年 Charles Louis Alphonse Laveran パウル・エールリヒ ドイツ帝国 1908 Paul Ehrlich 免疫の研究 年 イリヤ・メチニコフ ロシア連邦 Ilya Ilyich Mechnikov 1909 エーミール・コッハー スイス 甲状腺の生理学、病理学および外科学的研究 年 Emil Theodor Kocher 1910 アルブレヒト・コッセル 核酸物質を含む、タンパク質に関する研究による細胞化学 ドイツ帝国 年 Albrecht Kossel の知見への寄与 1911 アルヴァル・グルストランド スウェーデン 眼の屈折機能に関する研究 年 Allvar Gullstrand 1912 アレクシス・カレル フランス 血管縫合および臓器の移植に関する研究 年 Alexis Carrel 1913 シャルル・ロベール・リシェ フランス アナフィラキシーの研究 年 Charles Robert Richet 1914 ローベルト・バーラーニ オーストリア＝ハンガリー 内耳系の生理学および病理学に関する研究 年 Robert Bárány 帝国 1915 受賞者なし 年 1916 受賞者なし 年 1917 受賞者なし 年 1918 受賞者なし 年 1919 ジュール・ボルデ ベルギー 免疫に関する諸発見 年 Jules Bordet アウグスト・クローグ 1920 Schack August Steenberg デンマーク 毛細血管運動に関する調整機構の発見 年 Krogh 1921 受賞者なし 年 アーチボルド・ヒル イギリス 筋肉中の熱生成に関する発見 1922 Archibald Vivian Hill 年 オットー・マイヤーホフ ドイツ 筋肉における乳酸生成と酸素消費の固定的関連の発見 Otto Fritz Meyerhof
    [Show full text]
  • Image-Brochure-LNLM-2020-LQ.Pdf
    NOBEL LAUREATES PARTICIPATING IN LINDAU EVENTS SINCE 1951 Peter Agre | George A. Akerlof | Kurt Alder | Zhores I. Alferov | Hannes Alfvén | Sidney Altman | Hiroshi Amano | Philip W. Anderson | Christian B. Anfinsen | Edward V. Appleton | Werner Arber | Frances H. Arnold | Robert J. Aumann | Julius Axelrod | Abhijit Banerjee | John Bardeen | Barry C. Barish | Françoise Barré-Sinoussi | Derek H. R. Barton | Nicolay G. Basov | George W. Beadle | J. Georg Bednorz | Georg von Békésy |Eric Betzig | Bruce A. Beutler | Gerd Binnig | J. Michael Bishop | James W. Black | Elizabeth H. Blackburn | Patrick M. S. Blackett | Günter Blobel | Konrad Bloch | Felix Bloch | Nicolaas Bloembergen | Baruch S. Blumberg | Niels Bohr | Max Born | Paul Boyer | William Lawrence Bragg | Willy Brandt | Walter H. Brattain | Bertram N. Brockhouse | Herbert C. Brown | James M. Buchanan Jr. | Frank Burnet | Adolf F. Butenandt | Melvin Calvin Thomas R. Cech | Martin Chalfie | Subrahmanyan Chandrasekhar | Pavel A. Cherenkov | Steven Chu | Aaron Ciechanover | Albert Claude | John Cockcroft | Claude Cohen- Tannoudji | Leon N. Cooper | Carl Cori | Allan M. Cormack | John Cornforth André F. Cournand | Francis Crick | James Cronin | Paul J. Crutzen | Robert F. Curl Jr. | Henrik Dam | Jean Dausset | Angus S. Deaton | Gérard Debreu | Petrus Debye | Hans G. Dehmelt | Johann Deisenhofer Peter A. Diamond | Paul A. M. Dirac | Peter C. Doherty | Gerhard Domagk | Esther Duflo | Renato Dulbecco | Christian de Duve John Eccles | Gerald M. Edelman | Manfred Eigen | Gertrude B. Elion | Robert F. Engle III | François Englert | Richard R. Ernst Gerhard Ertl | Leo Esaki | Ulf von Euler | Hans von Euler- Chelpin | Martin J. Evans | John B. Fenn | Bernard L. Feringa Albert Fert | Ernst O. Fischer | Edmond H. Fischer | Val Fitch | Paul J.
    [Show full text]